APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 36 filers reported holding APPLIED MOLECULAR TRANS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,024 | -60.9% | 866,392 | -35.8% | 0.00% | – |
| Q2 2023 | $348,265 | -19.5% | 1,349,867 | -0.1% | 0.00% | – |
| Q1 2023 | $432,366 | -23.8% | 1,351,143 | 0.0% | 0.00% | – |
| Q4 2022 | $567,480 | -56.8% | 1,351,143 | +0.0% | 0.00% | – |
| Q3 2022 | $1,314,000 | -52.8% | 1,350,774 | +41.4% | 0.00% | – |
| Q2 2022 | $2,781,000 | -60.3% | 955,574 | +2.6% | 0.00% | – |
| Q1 2022 | $7,002,000 | -51.5% | 931,103 | -9.8% | 0.00% | – |
| Q4 2021 | $14,433,000 | -46.1% | 1,032,416 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $26,778,000 | -44.0% | 1,035,112 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $47,825,000 | +24.1% | 1,045,586 | +19.4% | 0.00% | 0.0% |
| Q1 2021 | $38,535,000 | +101.4% | 875,603 | +40.9% | 0.00% | 0.0% |
| Q4 2020 | $19,129,000 | +5.2% | 621,635 | +8.8% | 0.00% | 0.0% |
| Q3 2020 | $18,187,000 | +1969.1% | 571,573 | +1533.1% | 0.00% | – |
| Q2 2020 | $879,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ Capital Group, LLC | 9,075,488 | $126,875,000 | 22.54% |
| Founders Fund VI Management, LLC | 826,607 | $11,555,000 | 18.03% |
| Founders Fund V Management, LLC | 3,611,615 | $50,409,000 | 2.67% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 290,000 | $4,054,000 | 0.34% |
| Pinz Capital Management, LP | 42,800 | $598,000 | 0.23% |
| EcoR1 Capital, LLC | 400,000 | $5,592,000 | 0.18% |
| Burleson & Company, LLC | 87,462 | $1,223,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 64,153 | $897,000 | 0.11% |
| Virtus ETF Advisers LLC | 12,313 | $172,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 27,853 | $389,000 | 0.03% |